Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr;80(1):1-9.
doi: 10.1007/s12020-022-03236-z. Epub 2022 Oct 30.

Growth alterations in rare forms of primary adrenal insufficiency: a neglected issue in paediatric endocrinology

Affiliations
Review

Growth alterations in rare forms of primary adrenal insufficiency: a neglected issue in paediatric endocrinology

Rosario Ferrigno et al. Endocrine. 2023 Apr.

Abstract

Primary adrenal insufficiency (PAI) is an endocrine disorder characterized by direct adrenal failure, with consequent glucocorticoid, and eventually mineralocorticoid, deficiency. In children, the main cause of PAI is congenital adrenal hyperplasia (CAH), due to a loss of function of adrenal steroidogenic enzymes, but also rarer forms, including autoimmune polyglandular syndrome, adrenoleucodistrophy, adrenal hypoplasia congenita, familial glucocorticoid deficiency, and Allgrove's Syndrome, may be observed. In PAI children, growth alterations represent a major issue, as both inadequate and excessive glucocorticoid replacement treatment may lead to reduced growth rate and adult height impairment. However, growth abnormalities are poorly studied in rare forms of paediatric PAI, and specific studies on growth rate in these children are currently lacking. In the present review, the currently available evidence on growth alterations in children with rare PAI forms will be summarized, with a major focus on comorbidities with a potential impact on patients' growth rate.

Keywords: Adrenal insufficiency; Children; Growth; Growth rate; Height; Primay adrenal insufficiency.

PubMed Disclaimer

Similar articles

References

    1. E. Charmandari, N.C. Nicolaides, G.P. Chrousos, Adrenal insufficiency. Lancet 383(9935), 2152–2156 (2014) - PubMed - DOI
    1. T. Kirkgoz, T. Guran, Primary adrenal insufficiency in children: Diagnosis and management. Best. Pr. Res Clin. Endocrinol. Metab. 32(4), 397–424 (2018) - DOI
    1. M. Minnetti, S. Caiulo, R. Ferrigno et al. Abnormal linear growth in paediatric adrenal diseases: Pathogenesis, prevalence and management. Clin. Endocrinol. (Oxf.) 92(2), 98–108 (2020) - PubMed - DOI
    1. K. Muthusamy, M.B. Elamin, G. Smushkin et al. Clinical review: Adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis. J. Clin. Endocrinol. Metab. 95, 4161–4172 (2010) - PubMed - DOI
    1. G.J. Kahaly, L. Frommer, Polyglandular autoimmune syndromes. J. Endocrinol. Invest 41(1), 91–98 (2018) - PubMed - DOI

Substances

LinkOut - more resources